$INDP Heating Up After Hours! 🚀 +7% 🔹 Biotech momentum picking up as traders jump back into small-cap cancer therapy names 📈 🔹 Indaptus is developing Decoy2

$INDP Heating Up After Hours! 🚀 +7% 🔹 Biotech momentum picking up as traders jump back into small-cap cancer therapy names 📈 🔹 Indaptus is developing Decoy20, an immunotherapy candidate designed to activate both innate and adaptive immune responses against tumors 🧬 🔹 Company recently reported …